Primary pulmonary hypertension: The pressure rises for a gene

Journal of Clinical Pathology

Volumn 53, Issue 12, 2000, Pages 899-903

  Thomson, J R ^a   Trembath, R C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Chromosome 2q33; Genetics; Pulmonary hypertension

Indexed keywords

CHROMOSOME 2Q; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; LUNG BLOOD VESSEL; MOLECULAR CLONING; PATHOGENESIS; PEDIGREE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

CHROMOSOMES, HUMAN, PAIR 2; HUMANS; HYPERTENSION, PULMONARY; PEDIGREE;

EID: 0033675557     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.12.899     Document Type: Review

References (41)

1. ACCP consensus statement: Primary pulmonary hypertension
2. Primary pulmonary hypertension. Executive summary from the world symposium
3. Primary pulmonary hypertension: A national prospective study
4. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry
5. Primary pulmonary hypertension: Case series from the United Kingdom
6. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension
7. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension
8. Primary pulmonary hypertension: 1. Clinical and haemodynamic study
9. Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular disease
10. Familial primary pulmonary hypertension: Clinical patterns
11. Primary pulmonary hypertension in three sibs
12. Primary pulmonary hypertension: Familial occurrence
13. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension
14. The presence of genetic anticipation suggests that the molecular basis of familial primary pulmonary hypertension may be trinucleotide repeat expansion
15. Genetic basis of cardiomyopathy
16. Localisation of the gene for familial primary pulmonary hypertension to chromosome 2q31-32
17. Mapping of familial pulmonary hypertension locus (PPH1) to chromosome 2q31-32
18. Detection of familial primary pulmonary hypertension by genetic testing
19. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33
20. A physical and transcript map based upon refinement of the critical interval for PPHI, a gene for familial primary pulmonary hypertension
21. Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta
22. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
23. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension
24. Cellular and molecular mechanisms of pulmonary vascular remodelling
25. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
26. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
27. Dysfunctional voltage-gated potassium channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension
28. Attenuated potassium channel gene transcription in primary pulmonary hypertension
29. Aminorex and pulmonary hypertension. A review
30. Primary pulmonary hypertension and fenfluramine use
31. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
32. Action of fenfluramine on voltage gated K+ channels in human pulmonary artery smooth muscle cells
33. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
34. Primary pulmonary hypertension between inflammation and cancer
35. The intima: Development and monoclonal responses to injury
36. Mutation and cancer: Statistical study of retinoblastomas
37. Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome
38. Human immunodeficiency virus infection and pulmonary hypertension: Two new cases and a review of 86 reported cases
39. HIV-associated primary pulmonary hypertension
40. Clinical and pathological manifestations of pulmonary vascular disease in the toxic oil syndrome